FEDERICO GILBERTO
HAWKINS CARRANZA
Investigador hasta 2019
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (8)
2013
-
Comparative effects of teriparatide and risedronate in glucocorticoid- induced osteoporosis in men: 18-month results of the EuroGIOPs trial
Journal of Bone and Mineral Research, Vol. 28, Núm. 6, pp. 1355-1368
-
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis
Osteoporosis International, Vol. 24, Núm. 12, pp. 2971-2981
2011
2010
2009
-
Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis
Journal of Bone and Mineral Research
-
Response to comparison of teriparatide and strontium ranelate in postmenopausal women with osteoporosis
Journal of Bone and Mineral Research
2003
-
A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus
Clinical Therapeutics, Vol. 25, Núm. 4, pp. 1074-1095
-
Calidad de vida en pacientes osteoporóticas posmenopáusicas: Efecto del tratamiento con elcatonina
Revista Espanola de Enfermedades Metabolicas Oseas, Vol. 12, Núm. 2, pp. 46-51